ARTL Stock Analysis: Buy, Sell, or Hold?
ARTL - Artelo Biosciences, Inc. Common Stock
$1.01
-0.01 (-0.98%)
▼
5d:
-9.82%
30d:
-12.93%
90d:
-74.97%
HOLD
LOW Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Aug 12, 2026
14d
Get Alerted When ARTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARTL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ARTL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ARTL is currently trading at $1.01, which is considered oversold relative to its 30-day fair value range of $1.04 to $1.17.
Technical Outlook: Technically, ARTL is in a strong downtrend. The price is currently testing key support at $0.99. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.00 (+1682.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARTL is in a strong downtrend. The price is currently testing key support at $0.99. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.00 (+1682.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.04 -
$1.17
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1682.2% below Wall St target ($18.00)
- CAUTION: Recommendation downgraded due to -9.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.04 -
$1.17
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.99
Resistance Level
$1.24
Current Trend
Strong Downtrend
Technical data as of
Jul 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.19
Wall Street Target
$18.00
(+1682.2%)
Share & Embed Analysis
Last updated: July 28, 2026 3:12 AM ET
Data refreshes hourly during market hours. Next update: 4:12 AM
Data refreshes hourly during market hours. Next update: 4:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 60 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 51 HOLD |
